Heart failure patients who are discharged from the hospital before they reach euvolemia—a healthy balance of blood in the body—are more likely to be readmitted in both the short- and long-term, according to research published in the American Journal of Cardiology this month.

Hospice use in the U.S. has grown to nearly 5 percent among elderly patients with heart failure (HF), according to a JAMA Cardiology study published Aug. 29, but palliative care will likely become increasingly difficult as treatment continues to improve.

Less than two weeks after the FDA sent a warning letter to cardiologists about high mortality and stroke rates associated with SynCardia Systems’ Companion 2 (C2) Driver System, the company has published a response saying pre-implant risk factors were responsible for those outcomes.

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to run into clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

Oregon’s only heart transplant program has suspended operations for at least two weeks after three cardiologists either left or announced plans to leave Oregon Health & Science University, The Oregonian reported Aug. 27.

Although heart failure researchers have made strides in enrolling more racial and ethnic minorities in clinical trials, women and older patients remain underrepresented, according to a systematic review published in JAMA Cardiology.

A new study in JAMA Cardiology uncovered a set of genetic variants that are almost exclusive to people of African ancestry and may explain their higher risk of adverse events related to dilated cardiomyopathy (DCM).